| The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019 KB Tran, JJ Lang, K Compton, R Xu, AR Acheson, HJ Henrikson, ... The Lancet 400 (10352), 563-591, 2022 | 402 | 2022 |
| Global burden of cardiovascular diseases and risks, 1990-2022 GA Mensah, V Fuster, CJL Murray, GA Roth, ... Journal of the American College of Cardiology 82 (25), 2350-2473, 2023 | 65 | 2023 |
| Global, regional, and national burden of allergic disorders and their risk factors in 204 countries and territories, from 1990 to 2019: A systematic analysis for the Global … YH Shin, J Hwang, R Kwon, SW Lee, MS Kim, ... Allergy 78 (8), 2232-2254, 2023 | 47 | 2023 |
| Survival improvement for patients with metastatic colorectal cancer over twenty years FA Zeineddine, MA Zeineddine, A Yousef, Y Gu, S Chowdhury, A Dasari, ... NPJ Precision Oncology 7 (1), 16, 2023 | 40 | 2023 |
| Efficacy of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma: a randomized crossover trial JP Shen, AM Yousef, FA Zeineddine, MA Zeineddine, RS Tidwell, ... JAMA Network Open 6 (6), e2316161-e2316161, 2023 | 10 | 2023 |
| Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019 D Wu, Y Jin, Y Xing, MD Abate, M Abbasian, M Abbasi-Kangevari, ... EClinicalMedicine 64, 2023 | 8 | 2023 |
| Pancreatic cancer in the MENA region, a bibliometric review H Nassereldine, H Awada, AH Ali, M Zeineddine, ZA Sater, Y Shaib ecancermedicalscience 16, 2022 | 7 | 2022 |
| Prostate cancer in the Arab world: Bibliometric review and research priority recommendations AH Ali, H Awada, H Nassereldine, M Zeineddine, ZA Sater, A El-Hajj, ... Arab Journal of Urology 20 (2), 81-87, 2022 | 5 | 2022 |
| The status of bladder cancer research worldwide, a bibliometric review and recommendations H Awada, AH Ali, MA Zeineddine, H Nassereldine, Z Abdul Sater, ... Arab Journal of Urology 21 (1), 1-9, 2023 | 2 | 2023 |
| A prospective randomized crossover trial of systemic chemotherapy in patients with low-grade mucinous appendiceal adenocarcinoma JP Shen, AM Yousef, FA Zeineddine, MA Zeineddine, RS Tidwell, ... medRxiv, 2022.12. 06.22283164, 2022 | 2 | 2022 |
| Transcriptional Profiling and Consensus Molecular Subtype Assignment to Understand Response and Resistance to Anti–Epidermal Growth Factor Receptor Therapy in Colorectal Cancer S Chowdhury, R Gupta, J Millstein, K Lin, V Haridas, MA Zeineddine, ... JCO Precision Oncology 7, e2200422, 2023 | 1 | 2023 |
| Utility of circulating tumor DNA (ctDNA) in the management of appendiceal adenocarcinoma (AA). MA Zeineddine, FA Zeineddine, AMG Yousef, J Dansby, M White, ... Journal of Clinical Oncology 41 (4_suppl), 226-226, 2023 | 1 | 2023 |
| SO-40 Measurement of circulating tumor DNA (ctDNA) in appendiceal adenocarcinoma (AA): Prevalence, predictors, and correlation with clinical outcome MA Zeineddine, FA Zeineddine, A Yousef, M Overman, M White, A Uppal, ... Annals of Oncology 33, S374, 2022 | 1 | 2022 |
| Defining the subset of mutations in Polymerase Epsilon (POLE) associated with Loss-of-Proofreading (LOP) functionality. G Maddalena, FA Zeineddine, S Rivero-Hinojosa, VN Aushev, ... Annals of Oncology, 2024 | | 2024 |
| Efficacy and safety of atezolizumab and bevacizumab in appendiceal adenocarcinoma NJ Hornstein, MA Zeineddine, BB Gunes, AJ Pellatt, M Knafl, H Zhu, ... Cancer Research Communications, 2024 | | 2024 |
| Multi-Institutional Study Evaluating the Role of Circulating Tumor DNA in the Management of Appendiceal Cancers E Belmont, VV Bansal, MMG Yousef, MA Zeineddine, D Su, A Dhiman, ... JCO Precision Oncology 8, e2300531, 2024 | | 2024 |
| Cell-type-specific gene programs suggest immune and stromal drivers of relapse in colorectal cancer NJ Hornstein, M Wang, A Yousef, S Chowdhury, F Zeineddine, ... Cancer Research 84 (6_Supplement), 881-881, 2024 | | 2024 |
| KRAS Q61 mutations in patients with gastrointestinal malignancies and association with real-world clinical outcomes M Yousef, A Yousef, S Chowdhury, MM Fanaeian, M Knafl, PM Roy, ... Cancer Research 84 (6_Supplement), 2547-2547, 2024 | | 2024 |
| Serum Tumor Markers and Outcomes in Patients With Appendiceal Adenocarcinoma A Yousef, M Yousef, MA Zeineddine, A More, M Fanaeian, S Chowdhury, ... JAMA Network Open 7 (2), e240260-e240260, 2024 | | 2024 |
| Validation of the GATMO score in predicting non‐relapse mortality following hematopoietic cell transplant in multiple myeloma patients H Awada, A Hajj Ali, M Zeineddine, M Rashid, F Anwer, B Hamilton, ... European Journal of Haematology 112 (2), 314-316, 2024 | | 2024 |
John Paul ShenAssistant Professor, University of Texas MD Anderson Cancer CenterVerified email at alum.mit.edu
